International review of psychiatry (Abingdon, England) · 2025
Polygenic risk for psychiatric disorders and its association with neuropsychiatric symptoms in dementia.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Najar Jenna, de Rojas Itziar, Dalmasso Maria Carolina, Fernandez Maria Victoria, de Boer Sterre C M, Ramirez Alfredo, Priller Josef, Laske Christoph, Kleineidam Luca, Schneider Anja, Wagner Michael, Heilmann-Heimbach Stefanie, Scherer Martin, Froelich Lutz, Peters Oliver, Hellmann-Regen Julian, Wiltfang Jens, Düzel Emrah, Buerger Katharina, Perneczky Robert, Teipel Stefan, Jessen Frank, Kornhuber Johannes, Lemstra Afina W, Pijnenburg Yolande A L, van der Lee Sven J, Reus Lianne M
Аннотация
Neuropsychiatric symptoms are common in Alzheimer's disease (AD), dementia with Lewy bodies (DLB), and frontotemporal dementia (FTD), yet their genetic underpinnings remain unclear. To gain insight into biological processes related to neuropsychiatric symptoms in dementia, we investigated whether polygenic risk scores (PRS) for psychiatric disorders - major depressive disorder (MDD), schizophrenia (SCZ), bipolar disorder (BD), and autism spectrum disorder (ASD) - are associated with neuropsychiatric symptoms in dementia. Data included genetic and neuropsychiatric data of 6240 AD patients, 428 FTD patients and 390 DLB patients from five European cohorts (ADC, GR@ACE, DELCODE, AgeCoDe, and DCN). PRS for MDD, BD, SCZ, and ASD were calculated using LDpred2. Neuropsychiatric symptoms were assessed using total scores from the Neuropsychiatric Inventory (NPI) (NPI-12 and NPI-Q) and Geriatric Depression scale (GDS). Associations between PRS and symptoms were examined using linear regression models, followed by meta-analyses. In FTD, higher SCZ-PRS associated with lower NPI scores in the meta-analysis (β = -0.12, p = .001). No associations were found in AD and DLB. This is the first study to show that genetic liability for SCZ associates with lower NPI in FTD, warranting further investigation.